Journals / Medicine Science / 2021 / Cilt: 10 - Sayı: 4

From multiple myeloma to leishmaniasis: The cause is fever!

Pages
1540–1541
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this case, we describe a patient referred with a diagnosis of multiple myeloma, but ultimately diagnosed with leishmaniasis based on our evaluation, to draw attention to this disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Leishmaniasis is a vector-borne parasitic disease that constitutes a major public health problem.
📊
Key Findings & Data:Leishmaniasis presents with various clinical manifestations, from skin involvement to life-threatening visceral disease.
💡
Conclusion & Impact:In this case, we describe a patient referred with a diagnosis of multiple myeloma, but ultimately diagnosed with leishmaniasis based on our evaluation, to draw attention to this disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Leishmaniasis is a vector-borne parasitic disease that constitutes a major public health problem. Leishmaniasis presents with various clinical manifestations, from skin involvement to life-threatening visceral disease. Fever of unknown origin should be considered in the differential diagnosis. In this case, we describe a patient referred with a diagnosis of multiple myeloma, but ultimately diagnosed with leishmaniasis based on our evaluation, to draw attention to this disease.

🔖

Cite This Article

Sayin, S., Ugras, S., Basturk, A., Bağcı, M. (2022). From multiple myeloma to leishmaniasis: The cause is fever!. Medicine Science, Cilt: 10 - Sayı: 4, 1540–1541. https://ajindex.com/articles/579752

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Andrade-Narváez FJ, Vargas-González A, Canto-Lara SB, et al. Clinical picture of cutaneous leishmaniases due to Leishmania (Leishmania) mexicana in the Yucatan peninsula, Mexico. Mem Inst Oswaldo Cruz. 2001; 96:163–7
  2. Bladé J. Clinical practice. Monoclonal gammopathy of undetermined significance. N Engl J Med. 2006;355:2765-70
  3. Magill AJ. Leishmania species: Visceral (Kala-Azar), cutaneous, and mucosal leishmaniasis. In: Mandell GL, Bennet JE, Dolin R (eds.), Mandell, Douglas and Bennett’s principles and practice of infectious diseases. Churchill Livingstone, Philadelphia; 2015;3091–107
  4. Randi ML, Ruzzon E, Tezza F, et al. Monoclonal gammopathy in human leishmaniasis. Neth J Med. 2006;64:50-1
  5. Rombola F, Spinoso A, Bertuccio SN. Monoclonal gammopathy after visceral leishmaniasis: Just a coincidence? Infez Med. 2008;16:173-4
  6. Garcia-Menendez L, Santamaria Lopez C, Fernandez Eroles AL, et al. Monoclonal component in visceral leishmaniasis: A rare association that can lead to misdiagnosis. Rev Clin Esp. 1998;198:517-20
  7. Gabrielli GB, Zaia B, Stanzial AM, et al. Visceral leishmaniasis: A rarely diagnosed disease in northern Italy. Report of a case. Ann Ital Med Int. 2001;16:185-91.